<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: ISTA News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=ista</link><description>Latest Financial News for ISTA Pharmaceuticals, Inc.</description><language>en-us</language><lastBuildDate>Fri, 18 Dec 2009 19:26:18 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Today&apos;s 5-Star Movers (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12heeim62/*http%3A//www.fool.com/investing/general/2009/12/18/todays-five-star-movers.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/383330742</guid><pubDate>Fri, 18 Dec 2009 19:26:18 Etc/GMT</pubDate></item><item><title>ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM) (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091217/ny28140.html?.v=1</link><description>ISTA Pharmaceuticals, Inc. , today announced the Company submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for bromfenac ophthalmic solution dosed once-daily as a treatment for ocular inflammation and pain following cataract surgery.  ISTA currently markets Xibrom™ 0.09%, which is an eye drop labeled for use twice-daily, beginning 24 hours after cataract surgery.  If approved, ISTA plans to market the once-daily product under the brand name XiDay™.  </description><guid isPermaLink="false">yahoo_finance/3820826893</guid><pubDate>Thu, 17 Dec 2009 21:01:00 Etc/GMT</pubDate></item><item><title>ISTA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091217/ista8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/4229046645</guid><pubDate>Thu, 17 Dec 2009 17:01:04 Etc/GMT</pubDate></item><item><title>The Best Investing Ideas in Defensive Stocks (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=136dbgqm2/*http%3A//www.fool.com/investing/general/2009/12/17/the-best-investing-ideas-in-defensive-stocks.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3843844227</guid><pubDate>Thu, 17 Dec 2009 16:49:02 Etc/GMT</pubDate></item><item><title>ISTA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091211/ista8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/459347875</guid><pubDate>Fri, 11 Dec 2009 19:47:28 Etc/GMT</pubDate></item><item><title>Today&apos;s 5-Star Movers (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12h7hjr0d/*http%3A//www.fool.com/investing/general/2009/12/02/todays-five-star-movers.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2472273254</guid><pubDate>Wed, 2 Dec 2009 17:05:14 Etc/GMT</pubDate></item><item><title>Dream Stocks for Biotech Investors (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12sgb5d6a/*http%3A//www.fool.com/investing/general/2009/11/25/dream-stocks-for-biotech-investors.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2380077584</guid><pubDate>Wed, 25 Nov 2009 20:27:20 Etc/GMT</pubDate></item><item><title>Build Your Fortune With These Winners (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12vv8cdbp/*http%3A//www.fool.com/investing/general/2009/11/25/build-your-fortune-with-these-winners.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/802661081</guid><pubDate>Wed, 25 Nov 2009 20:00:32 Etc/GMT</pubDate></item><item><title>ISTA PHARMACEUTICALS INC Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=ista</link><description></description><guid isPermaLink="false">yahoo_finance/2807763945</guid><pubDate>Wed, 11 Nov 2009 14:04:58 Etc/GMT</pubDate></item><item><title>ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma &amp; Immunology (ACAAI) (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091109/ny06291.html?.v=1</link><description>ISTA Pharmaceuticals, Inc. , today announced additional results from the Company&apos;s Bepreve 1.5% Phase 3 clinical studies.</description><guid isPermaLink="false">yahoo_finance/364946154</guid><pubDate>Mon, 9 Nov 2009 12:30:00 Etc/GMT</pubDate></item><item><title>ISTA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091105/ista10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/2750651516</guid><pubDate>Thu, 5 Nov 2009 22:26:46 Etc/GMT</pubDate></item><item><title>New Star Analyst Rankings for ISTA Pharmaceuticals, Inc. (StarMine)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/i/ista.html</link><description></description><guid isPermaLink="false">yahoo_finance/3469761055</guid><pubDate>Wed, 4 Nov 2009 14:28:52 Etc/GMT</pubDate></item><item><title>ISTA Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/3/107533.html</link><description></description><guid isPermaLink="false">yahoo_finance/3841371905</guid><pubDate>Tue, 3 Nov 2009 22:00:00 Etc/GMT</pubDate></item><item><title>ISTA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091103/ista8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/4246069941</guid><pubDate>Tue, 3 Nov 2009 21:06:46 Etc/GMT</pubDate></item><item><title>ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091103/ny04491.html?.v=1</link><description>ISTA Pharmaceuticals, Inc.</description><guid isPermaLink="false">yahoo_finance/237472832</guid><pubDate>Tue, 3 Nov 2009 21:00:00 Etc/GMT</pubDate></item><item><title>Q3 2009 ISTA Pharmaceuticals, Inc. Earnings Release - After Market Close (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091103.html?t=ista</link><description></description><guid isPermaLink="false">yahoo_finance/3210986791</guid><pubDate>Tue, 3 Nov 2009 12:07:28 Etc/GMT</pubDate></item><item><title>[video] Top $5 Stocks (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/video/ts/rss/SIG=126i9tten/*http%3A//www.thestreet.com/_yahoo/story/10615016/1/top-5-stocks.html?cm_ven=YAHOOV&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/3777143993</guid><pubDate>Thu, 22 Oct 2009 08:59:59 Etc/GMT</pubDate></item><item><title>ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091021/ny96341.html?.v=1</link><description>ISTA Pharmaceuticals, Inc. today announced poster presentations of results from the Company&apos;s Bepreve 1.5% Phase 3 clinical studies in allergic conjunctivitis.</description><guid isPermaLink="false">yahoo_finance/1316110642</guid><pubDate>Wed, 21 Oct 2009 20:01:00 Etc/GMT</pubDate></item><item><title>ISTA Pharmaceuticals to Present at 2009 BIOCOM Investor Conference (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091020/ny95383.html?.v=1</link><description>ISTA Pharmaceuticals, Inc. , today announced it will present at the 2009 BIOCOM Investor Conference at 11:30 a.m. Pacific Time on October 27, 2009, at the Hyatt Regency La Jolla in San Diego, California.</description><guid isPermaLink="false">yahoo_finance/3512446220</guid><pubDate>Tue, 20 Oct 2009 16:00:00 Etc/GMT</pubDate></item><item><title>ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091002/ny86098.html?.v=1</link><description>ISTA Pharmaceuticals, Inc. , today announced it will release third quarter 2009 financial results after market close on November 3, 2009. In conjunction, the Company will host a conference call at 5:00 p.m.</description><guid isPermaLink="false">yahoo_finance/1148802719</guid><pubDate>Fri, 2 Oct 2009 16:15:00 Etc/GMT</pubDate></item></channel></rss><!-- c2.finance.sp2.yahoo.com compressed/chunked Wed Dec 30 20:24:14 PST 2009 -->
